Lack of association of the CIITA -168A→G promoter SNP with myasthenia gravis and its role in autoimmunity

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Ramanujam, Ryan ^a   Zhao, Yaofeng ^a   Pirskanen, Ritva ^a   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II TRANSACTIVATOR; UNCLASSIFIED DRUG; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; COHORT ANALYSIS; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; MIDDLE AGED; NEWBORN; PROGNOSIS; PROMOTER REGION;

ADULT; AUTOIMMUNITY; CASE-CONTROL STUDIES; COHORT STUDIES; HUMANS; INFANT, NEWBORN; MIDDLE AGED; MYASTHENIA GRAVIS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS, GENETIC; SWEDEN; TRANS-ACTIVATORS;

EID: 77957744667     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-147     Document Type: Article

References (30)

1. Giraud M, Vandiedonck C, Garchon H. Genetic factors in autoimmune myasthenia gravis. Ann N Y Acad Sci 2008, 1132:180-192. 10.1196/annals.1405.027, 18567868.
2. Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993, 75:135-146.
3. LeibundGut-Landmann S, Waldburger J, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol 2004, 34:1513-1525. 10.1002/eji.200424964, 15162420.
4. Swanberg M, Lidman O, Padyukov L, Eriksson P, Akesson E, Jagodic M, Lobell A, Khademi M, Börjesson O, Lindgren CM, Lundman P, Brookes AJ, Kere J, Luthman H, Alfredsson L, Hillert J, Klareskog L, Hamsten A, Piehl F, Olsson T. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet 2005, 37:486-94. 10.1038/ng1544, 15821736.
5. Drachman DB. Myasthenia gravis. N Engl J Med 1994, 330:1797-1810. 10.1056/NEJM199406233302507, 8190158.
6. Hannelius U, Lindgren CM, Melén E, Malmberg A, von Dobeln U, Kere J. Phenylketonuria screening registry as a resource for population genetic studies. J Med Genet 2005, 42:e60. 10.1136/jmg.2005.032987, 1735924, 16199543.
7. Jurinke C, van den Boom D, Cantor CR, Köster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 2002, 187:179-192.
8. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213. 10.1038/ng1706, 16415888.
9. Chan K, Cheung R, Mak W, Ho S. Nonthymoma early-onset- and late-onset-generalized myasthenia gravis--A retrospective hospital-based study. Clinical Neurology and Neurosurgery 2007, 109:686-691. 10.1016/j.clineuro.2007.05.023, 17644246.
10. Gilhus NE. Autoimmune myasthenia gravis. Expert Rev Neurother 2009, 9:351-358. 10.1586/14737175.9.3.351, 19271944.
11. Meriggioli MN. Myasthenia Gravis with Anti-Acetylcholine Receptor Antibodies. Front Neurol Neurosci 2009, 26:94-108. full_text, 19349707.
12. Orozco G, Robledo G, Linga Reddy MVP, García A, Pascual-Salcedo D, Balsa A, González-Gay MA, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, Petersson IF, Alarcón-Riquelme M, Martín J. Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations. Rheumatology (Oxford) 2006, 45:1442-1444. 10.1093/rheumatology/kel272, 16935917.
13. Iikuni N, Ikari K, Momohara S, Tomatsu T, Hara M, Yamanaka H, Okamoto H, Kamatani N. MHC2TA is associated with rheumatoid arthritis in Japanese patients. Ann Rheum Dis 2007, 66:274-275. 10.1136/ard.2006.063347, 1798499, 17090564.
14. Bronson PG, Criswell LA, Barcellos LF. The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association. Ann Rheum Dis 2008, 67:933-6. 10.1136/ard.2007.077099, 2951320, 17875550.
15. Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Wolff AB, Løvås K, Egeland T, Undlien DE. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 2008, 93:3310-3317.
16. Ghaderi M, Gambelunghe G, Tortoioli C, Brozzetti A, Jatta K, Gharizadeh B, De Bellis A, Pecori Giraldi F, Terzolo M, Betterle C, Falorni A. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency. J Clin Endocrinol Metab 2006, 91:4107-4111. 10.1210/jc.2006-0855, 16849401.
17. Linga-Reddy MVP, Gunnarsson I, Svenungsson E, Sturfelt G, Jönsen A, Truedsson L, Nordmark G, Rönnblom L, Alarcón-Riquelme ME. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus. Tissue Antigens 2007, 70:412-4. 10.1111/j.1399-0039.2007.00920.x, 17711409.
18. Martínez A, Perdigones N, Cénit M, Espino L, Varadé J, Lamas JR, Santiago JL, Fernández-Arquero M, de la Calle H, Arroyo R, de la Concha EG, Fernandez-Gutierrez B, Urcelay E. Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 2009,
19. Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Sawcer SJ, Pericak-Vance MA, Haines JL, Hauser SL, Oksenberg JR, Barcellos LF. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet 2010, 19:2331-2340. 10.1093/hmg/ddq101, 20211854.
20. Koizumi K, Okamoto H, Iikuni N, Nakamura T, Kawamoto M, Momohara S, Ichikawa N, Furuya T, Kotake S, Taniguchi A, Yamanaka H, Kamatani N. Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus. Ann Rheum Dis 2005, 64:947-50. 10.1136/ard.2004.025767, 1755521, 15897313.
21. Yazdani-Biuki B, Brickmann K, Wohlfahrt K, Mueller T, März W, Renner W, Gutjahr M, Langsenlehner U, Krippl P, Wascher TC, Paulweber B, Graninger W, Brezinschek H. The MHC2TA -168A > G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients. Arthritis Res Ther 2006, 8:R97. 10.1186/ar1974, 1779415, 16776848.
22. Akkad DA, Jagiello P, Szyld P, Goedde R, Wieczorek S, Gross WL, Epplen JT. Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups. Int J Immunogenet 2006, 33:59-61. 10.1111/j.1744-313X.2006.00568.x, 16426246.
23. Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D, Worthington J, Barton A. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis Rheum 2006, 54:3417-22. 10.1002/art.22166, 17075826.
24. Lindholm E, Melander O, Almgren P, Berglund G, Agardh C, Groop L, Orho-Melander M. Polymorphism in the MHC2TA Gene Is Associated with Features of the Metabolic Syndrome and Cardiovascular Mortality. PLoS ONE 2006, 1:e64. 10.1371/journal.pone.0000064, 1762368, 17183695.
25. O'Doherty C, Hawkins S, Rooney M, Vandenbroeck K. The MHC2TA-168A/G and +1614G/C polymorphisms and risk for multiple sclerosis or chronic inflammatory arthropathies. Tissue Antigens 2007, 70:247-51. 10.1111/j.1399-0039.2007.00876.x, 17661914.
26. Martinez A, et al. Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis 2007, 66(3):325-329. 10.1136/ard.2006.059428, 1855999, 17012290.
27. Harrison P, Pointon JJ, Farrar C, Harin A, Wordsworth BP. MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford) 2007, 46:409-411. 10.1093/rheumatology/kel300, 16920747.
28. Sánchez E, Sabio JM, Jiménez-Alonso J, Callejas JL, Camps M, de Ramón E, García-Portales R, de Haro M, Ortego-Centeno N, López-Nevot MA, Martín J. Study of two polymorphisms of the MHC2TA gene with systemic lupus erythematosus. Rheumatology (Oxford) 2008, 47:102-3. 10.1093/rheumatology/kem242, 17956914.
29. Pan-Hammarström Q, Hammarström L. Antibody deficiency diseases. Eur J Immunol 2008, 38:327-33. 10.1002/eji.200737927, 18200502.
30. Dema B, Martínez A, Fernández-Arquero M, Maluenda C, Polanco I, Angeles Figueredo M, de la Concha EG, Urcelay E, Núñez C. Autoimmune disease association signals in CIITA and KIAA0350 are not involved in celiac disease susceptibility. Tissue Antigens 2009, 73:326-329. 10.1111/j.1399-0039.2009.01216.x, 19317741.